Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 218

Results For "IMI"

3813 News Found

Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
News | March 06, 2023

Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent

This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry


Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments
News | March 04, 2023

Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments

The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients


Caplin Steriles gets USFDA approval for Rocuronium Bromide Injection
Drug Approval | March 04, 2023

Caplin Steriles gets USFDA approval for Rocuronium Bromide Injection

Rocuronium Bromide Injection is a neuromuscular blocking agent


Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
Drug Approval | March 04, 2023

Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution

Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States


Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi
News | March 04, 2023

Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi

Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme


Vaishali Pharma bags Rs 600 crore order for antibiotics pharmaceutical products
News | March 03, 2023

Vaishali Pharma bags Rs 600 crore order for antibiotics pharmaceutical products

This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.


Zydus receives final approval from the USFDA for Acyclovir Cream
Drug Approval | March 03, 2023

Zydus receives final approval from the USFDA for Acyclovir Cream

he product will be launched shortly in the US market.


5 crore health records of individuals linked to their ABHA for anytime access
Policy | March 01, 2023

5 crore health records of individuals linked to their ABHA for anytime access

With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)


Zydus receives final approval from the USFDA for Apixaban Tablets
Drug Approval | March 01, 2023

Zydus receives final approval from the USFDA for Apixaban Tablets

Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).


Vaishali Pharma receives multiple orders worth US$ 73.85 million
News | March 01, 2023

Vaishali Pharma receives multiple orders worth US$ 73.85 million

This order is subject to initial advance payment as per the agreed terms of the contract